BIOMAT Database Logo BIOMAT Database Logo

Xeroderma pigmentosum variant: response to etretinate. 1990

J Berth-Jones, and R A Graham-Brown
Department of Dermatology, Leicester Royal Infirmary, U.K.

We report a case of the variant form of xeroderma pigmentosum in whom tumour development was completely suppressed for 22 months by etretinate 25 mg daily.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004260 DNA Repair The removal of DNA LESIONS and/or restoration of intact DNA strands without BASE PAIR MISMATCHES, intrastrand or interstrand crosslinks, or discontinuities in the DNA sugar-phosphate backbones. DNA Damage Response
D005050 Etretinate An oral retinoid used in the treatment of keratotic genodermatosis, lichen planus, and psoriasis. Beneficial effects have also been claimed in the prophylaxis of epithelial neoplasia. The compound may be teratogenic. B10-9359,Ethyl Etrinoate,Ro 10-9359,Ro-10-9359,Tigason,Tigazon,B10 9359,B109359,Etrinoate, Ethyl,Ro 10 9359,Ro 109359,Ro109359
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm
D014983 Xeroderma Pigmentosum A rare, pigmentary, and atrophic autosomal recessive disease. It is manifested as an extreme photosensitivity to ULTRAVIOLET RAYS as the result of a deficiency in the enzyme that permits excisional repair of ultraviolet-damaged DNA. Kaposi Disease,Kaposi's Disease,Kaposis Disease

Related Publications

J Berth-Jones, and R A Graham-Brown
Treatment of xeroderma pigmentosum variant with low-dose etretinate.
April 1996, The British journal of dermatology,
J Berth-Jones, and R A Graham-Brown
[Xeroderma pigmentosum: prevention of tumors with etretinate].
March 1984, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
J Berth-Jones, and R A Graham-Brown
[Variant-type xeroderma pigmentosum].
January 1986, Annales de dermatologie et de venereologie,
J Berth-Jones, and R A Graham-Brown
[A case of xeroderma pigmentosum treated by oral etretinate].
August 1990, Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology,
J Berth-Jones, and R A Graham-Brown
Xeroderma pigmentosum variant cells are resistant to immortalization.
September 1995, Mutation research,
J Berth-Jones, and R A Graham-Brown
Molecular genetics of Xeroderma pigmentosum variant.
October 2003, Experimental dermatology,
J Berth-Jones, and R A Graham-Brown
Xeroderma pigmentosum variant with multisystem involvement.
September 1992, Archives of dermatology,
J Berth-Jones, and R A Graham-Brown
Xeroderma pigmentosum variant or pigmented xerodermoid.
January 1997, Anticancer research,
J Berth-Jones, and R A Graham-Brown
Xeroderma pigmentosum variant associated with multiple cancers.
January 1999, Photodermatology, photoimmunology & photomedicine,
J Berth-Jones, and R A Graham-Brown
XP43TO, previously classified as xeroderma pigmentosum Group E, should be reclassified as xeroderma pigmentosum variant.
December 2001, The Journal of investigative dermatology,
Copied contents to your clipboard!